Teva Pharmaceuticals @TevaUSA
Regulatory uncertainty and unpredictability are obstacles to paving the way for new generic launches, said Teva’s Scott Tomsky, VP Regulatory Affairs for North America Generics at a recent FDA meeting. #Generics https://t.co/9ZYrz4VE8W https://t.co/vvOsRL3H1r — PolitiTweet.org